Oslo - Delayed Quote NOK

Vistin Pharma ASA (VISTN.OL)

Compare
23.10
-0.30
(-1.28%)
At close: 4:25:20 PM GMT+1
Currency in NOK All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
423,587.00
435,391.00
287,675.00
275,812.00
253,159.00
Cost of Revenue
205,457.00
233,150.00
199,876.00
143,935.00
110,216.00
Gross Profit
218,130.00
202,241.00
87,799.00
131,877.00
142,943.00
Operating Expense
135,462.00
133,644.00
93,895.00
98,627.00
97,387.00
Operating Income
82,668.00
68,597.00
-6,096.00
33,250.00
45,556.00
Net Non Operating Interest Income Expense
3,995.00
-2,157.00
-2,424.00
-127.00
811.00
Pretax Income
78,741.00
58,518.00
-6,008.00
31,995.00
-124,272.00
Tax Provision
17,372.00
12,923.00
-1,293.00
7,129.00
-27,317.00
Net Income Common Stockholders
61,369.00
45,596.00
-4,716.00
24,867.00
-96,955.00
Diluted NI Available to Com Stockholders
61,369.00
45,596.00
-4,716.00
24,867.00
-96,955.00
Basic EPS
1.54
1.03
-0.11
0.56
-2.19
Diluted EPS
1.54
1.03
-0.11
0.56
-2.19
Basic Average Shares
44,345.00
44,345.00
44,345.00
44,345.00
44,345.00
Diluted Average Shares
44,345.00
44,345.00
44,345.00
44,345.00
44,345.00
Total Operating Income as Reported
82,669.00
68,598.00
-6,095.00
33,250.00
45,555.00
Total Expenses
340,919.00
366,794.00
293,771.00
242,562.00
207,603.00
Net Income from Continuing & Discontinued Operation
61,369.00
45,596.00
-4,716.00
24,867.00
-96,955.00
Normalized Income
61,369.00
45,596.00
-4,716.00
24,867.00
17,549.00
Interest Income
-7,206.00
220.00
28.00
265.00
1,721.00
Interest Expense
-11,312.00
2,266.00
2,140.00
357.00
820.00
Net Interest Income
3,995.00
-2,157.00
-2,424.00
-127.00
811.00
EBIT
67,429.00
60,784.00
-3,868.00
32,352.00
-123,452.00
EBITDA
86,373.00
78,131.00
8,412.00
42,961.00
-113,829.00
Reconciled Cost of Revenue
205,457.00
233,150.00
199,876.00
143,935.00
110,216.00
Reconciled Depreciation
18,944.00
17,347.00
12,280.00
10,609.00
9,623.00
Net Income from Continuing Operation Net Minority Interest
61,369.00
45,596.00
-4,716.00
24,867.00
-96,955.00
Total Unusual Items Excluding Goodwill
-109,329.00
--
--
--
-146,800.00
Total Unusual Items
-109,329.00
--
--
--
-146,800.00
Normalized EBITDA
86,373.00
78,131.00
8,412.00
42,961.00
32,971.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
--
-32,296.00
12/31/2020 - 6/10/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers